Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. IONQ
3. USO
4. IONS
5. ACN
6. AZN
7. ROIV
8. AAPL
9. NVDA
10. ORCL

Go back to Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: NRIX) Delayed: 26.06 -0.08 (0.31%)
Previous Close $26.14    52 Week High $ 
Open $25.42    52 Week Low $ 
Day High $26.42    P/E N/A 
Day Low $25.36    EPS $ 
Volume 891,301